Carlos Bonilla
Corporate Officer/Principal at Carlos J. Bonilla & Associates PL
Net worth: 1 M $ as of 2024-05-30
Profile
Carlos J.
Bonilla is currently the Principal of Mr. Bonilla & Associates PL.
Previously, he worked as a Director at XenaCare Holdings, Inc.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
LA ROSA HOLDINGS CORP.
6.82% | 2024-04-15 | 1,010,840 ( 6.82% ) | 1 M $ | 2024-05-30 |
Carlos Bonilla active positions
| Companies | Position | Start |
|---|---|---|
| Carlos J. Bonilla & Associates PL | Corporate Officer/Principal | 2011-05-11 |
Former positions of Carlos Bonilla
| Companies | Position | End |
|---|---|---|
XenaCare Holdings, Inc.
 XenaCare Holdings, Inc. Pharmaceuticals: OtherHealth Technology XenaCare Holdings, Inc. engages in the formulation, marketing and distribution of nutrition supplement products. It offers Cobroxin for pain medication, XenaCor and XenaTri for cardiovascular health, XenaZyme Plus supports digestion and SunPill for skin protection against ultraviolet rays. The company was founded by Alan P. Xenakis in June 2005 and is headquartered in Tampa, FL. | Director/Board Member | - |
Experiences
Positions held
Linked companies
| Private companies | 2 |
|---|---|
XenaCare Holdings, Inc.
XenaCare Holdings, Inc. Pharmaceuticals: OtherHealth Technology XenaCare Holdings, Inc. engages in the formulation, marketing and distribution of nutrition supplement products. It offers Cobroxin for pain medication, XenaCor and XenaTri for cardiovascular health, XenaZyme Plus supports digestion and SunPill for skin protection against ultraviolet rays. The company was founded by Alan P. Xenakis in June 2005 and is headquartered in Tampa, FL. | Health Technology |
| Carlos J. Bonilla & Associates PL |
- Stock Market
- Insiders
- Carlos Bonilla
